[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Zolmitriptan.]
[M03AB01, succinylcholine, The risk or severity of adverse effects can be increased when Succinylcholine is combined with Zolmitriptan.]
[M01AB02, sulindac, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Sulindac.]
[N05AL01, sulpiride, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Sulpiride.]
[N03AX03, sulthiame, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Sulthiame.]
[M01AX04, apazone, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Azapropazone.]
[N06DA01, tacrine, The metabolism of Tacrine can be decreased when combined with Zolmitriptan.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Zolmitriptan.]
[N05CD07, temazepam, The risk or severity of adverse effects can be increased when Temazepam is combined with Zolmitriptan.]
[R03CC03, terbutaline, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Terbutaline.]
[S01HA03, tetracaine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tetracaine.]
[N05AE05, lurasidone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Lurasidone.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Apomorphine.]
[L04AX02, thalidomide, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA07, theobromine, The metabolism of Theobromine can be decreased when combined with Zolmitriptan.]
[R03DA04, theophylline, The metabolism of Zolmitriptan can be decreased when combined with Theophylline.]
[P02CA02, thiabendazole, The metabolism of Zolmitriptan can be decreased when combined with Thiabendazole.]
[R06AD03, thiethylperazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Thiethylperazine.]
[N05CA19, thiopental, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Thiopental.]
[N05AB08, thioproperazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Thioproperazine.]
[N05AC02, thioridazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Thiothixene.]
[G04BE06, moxisylyte, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Moxisylyte.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tiapride.]
[B01AC05, ticlopidine, The metabolism of Zolmitriptan can be decreased when combined with Ticlopidine.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tilidine.]
[S01ED01, timolol, Zolmitriptan may decrease the antihypertensive activities of Timolol.]
[M02AX02, tolazoline, Zolmitriptan may decrease the antihypertensive activities of Tolazoline.]
[M02AA21, tolmetin, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Tolmetin.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tolperisone.]
[N02AX02, tramadol, The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Tramadol.]
[N06AF04, tranylcypromine, The risk or severity of serotonin syndrome can be increased when Tranylcypromine is combined with Zolmitriptan.]
[N06AX05, trazodone, The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Zolmitriptan.]
[C03DB02, triamterene, The metabolism of Triamterene can be decreased when combined with Zolmitriptan.]
[N05CD05, triazolam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Triazolam.]
[C03AA06, trichlormethiazide, Zolmitriptan may decrease the antihypertensive activities of Trichlormethiazide.]
[A03AB12, mepenzolate, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[N05AB06, trifluoperazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Trifluoperazine.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Trifluperidol.]
[N05AA05, triflupromazine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Triflupromazine.]
[N04AA01, trihexyphenidyl, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[A03AA05, trimebutine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.]
[R06AD01, trimeprazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Alimemazine.]
[N03AC02, trimethadione, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Trimethadione.]
[C02BA01, trimethaphan, Zolmitriptan may decrease the antihypertensive activities of Trimethaphan.]
[N06AA06, trimipramine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Trimipramine.]
[R06AX07, triprolidine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Triprolidine.]
[A03BB01, butylscopolamine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[N06AX24, vilazodone, The risk or severity of vasospastic reactions can be increased when Vilazodone is combined with Zolmitriptan.]
[N06AX02, tryptophan, The risk or severity of adverse effects can be increased when Tryptophan is combined with Zolmitriptan.]
[C09CA09, azilsartan medoxomil, Zolmitriptan may decrease the antihypertensive activities of Azilsartan medoxomil.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tubocurarine.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be decreased when combined with Zolmitriptan.]
[L02BX03, abiraterone, The metabolism of Zolmitriptan can be decreased when combined with Abiraterone.]
[N03AX21, ezogabine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ezogabine.]
[R03AC18, indacaterol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Indacaterol.]
[C08DA01, verapamil, The metabolism of Verapamil can be decreased when combined with Zolmitriptan.]
[N06AX09, viloxazine, The metabolism of Zolmitriptan can be decreased when combined with Viloxazine.]
[C04AX07, vincamine, Zolmitriptan may decrease the antihypertensive activities of Vincamine.]
[B01AA03, warfarin, The metabolism of Warfarin can be decreased when combined with Zolmitriptan.]
[N01AX15, xenon, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Xenon.]
[C03BA10, xipamide, Zolmitriptan may decrease the antihypertensive activities of Xipamide.]
[N05AF05, zuclopenthixol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Zuclopenthixol.]
[N03AX14, levetiracetam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Levetiracetam.]
[L01EC01, vemurafenib, The serum concentration of Zolmitriptan can be increased when it is combined with Vemurafenib.]
[J01MA13, trovafloxacin, The metabolism of Zolmitriptan can be decreased when combined with Trovafloxacin.]
[N05AE04, ziprasidone, The risk or severity of vasospastic reactions can be increased when Ziprasidone is combined with Zolmitriptan.]
[N02BA01, aspirin, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Acetylsalicylic acid.]
[G04BD07, tolterodine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.]
[C07AB03, atenolol, Zolmitriptan may decrease the antihypertensive activities of Atenolol.]
[L03AB11, peginterferon alfa-2a, The metabolism of Zolmitriptan can be decreased when combined with Peginterferon alfa-2a.]
[M03AC04, atracurium, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Atracurium.]
[S01FA01, atropine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Atropine.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Zolmitriptan.]
[L04AX01, azathioprine, The metabolism of Azathioprine can be decreased when combined with Zolmitriptan.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.]
[A08AA11, lorcaserin, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Lorcaserin.]
[G04BD12, mirabegron, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Mirabegron.]
[L04AA31, teriflunomide, The serum concentration of Zolmitriptan can be decreased when it is combined with Teriflunomide.]
[C01CA18, octopamine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Octopamine.]
[N05CA04, barbital, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Barbital.]
[L01AA09, bendamustine, The metabolism of Bendamustine can be decreased when combined with Zolmitriptan.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.]
[N04BD02, rasagiline, The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Zolmitriptan.]
[C08CA13, lercanidipine, Zolmitriptan may decrease the antihypertensive activities of Lercanidipine.]
[A03FA09, mosapride, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Mosapride.]
[N06DA02, donepezil, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Donepezil.]
[N03AX22, perampanel, Perampanel may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.]
[J01MB04, pipemidic acid, The metabolism of Zolmitriptan can be decreased when combined with Pipemidic acid.]
[R06AC06, thonzylamine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Diethyl ether.]
[C03AA01, bendroflumethiazide, Zolmitriptan may decrease the antihypertensive activities of Bendroflumethiazide.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Pomalidomide.]
[N02BA10, benorilate, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Benorilate.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Benperidol.]
[J01MA15, gemifloxacin, The metabolism of Zolmitriptan can be decreased when combined with Gemifloxacin.]
[S01AE07, moxifloxacin, The metabolism of Zolmitriptan can be decreased when combined with Moxifloxacin.]
[A06AX06, tegaserod, The metabolism of Zolmitriptan can be decreased when combined with Tegaserod.]
[R02AD01, benzocaine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Benzocaine.]
[M01AH01, celecoxib, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Celecoxib.]
[N02CC02, naratriptan, The risk or severity of vasospastic reactions can be increased when Naratriptan is combined with Zolmitriptan.]
[N04AC01, benztropine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.]
[L01EC02, dabrafenib, The metabolism of Zolmitriptan can be decreased when combined with Dabrafenib.]
[R02AX03, benzydamine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Benzydamine.]
[P03AX06, benzyl alcohol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Benzyl alcohol.]
[N06AX28, levomilnacipran, The risk or severity of serotonin syndrome can be increased when Levomilnacipran is combined with Zolmitriptan.]
[C08EA02, bepridil, Zolmitriptan may decrease the antihypertensive activities of Bepridil.]
[C02KX05, riociguat, Zolmitriptan may decrease the antihypertensive activities of Riociguat.]
[C02KX04, macitentan, Zolmitriptan may decrease the antihypertensive activities of Macitentan.]
[N06AX26, vortioxetine, The risk or severity of vasospastic reactions can be increased when Vortioxetine is combined with Zolmitriptan.]
[N03AF04, eslicarbazepine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Zolmitriptan can be decreased when combined with Simeprevir.]
[N03AG04, vigabatrin, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Vigabatrin.]
[A10BK01, dapagliflozin, The metabolism of Zolmitriptan can be decreased when combined with Dapagliflozin.]
[C01CA27, droxidopa, Zolmitriptan may increase the hypertensive activities of Droxidopa.]
[C07AB04, acebutolol, Zolmitriptan may decrease the antihypertensive activities of Acebutolol.]
[N05CH03, tasimelteon, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tasimelteon.]
[L04AA32, apremilast, The metabolism of Zolmitriptan can be increased when combined with Apremilast.]
[S01ED02, betaxolol, The metabolism of Zolmitriptan can be decreased when combined with Betaxolol.]
[C02CC01, bethanidine, Zolmitriptan may decrease the antihypertensive activities of Bethanidine.]
[L04AC11, siltuximab, The metabolism of Zolmitriptan can be increased when combined with Siltuximab.]
[A03BA03, hyoscyamine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Zolmitriptan.]
[L01XH04, belinostat, The metabolism of Zolmitriptan can be increased when combined with Belinostat.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Alfaxalone.]
[R03AC19, olodaterol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Olodaterol.]
[D11AA01, glycopyrronium, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[N05CM19, suvorexant, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AA04, acepromazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Acepromazine.]
[N04AA02, biperiden, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[L04AX05, pirfenidone, The metabolism of Zolmitriptan can be decreased when combined with Pirfenidone.]
[B01AA01, dicumarol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dicoumarol.]
[N06AX11, mirtazapine, Zolmitriptan may increase the serotonergic activities of Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Zolmitriptan can be increased when combined with Secukinumab.]
[N02BE01, acetaminophen, The metabolism of Acetaminophen can be decreased when combined with Zolmitriptan.]
[A03AA09, difemerine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[B01AA11, tioclomarol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tioclomarol.]
[A07DA06, eluxadoline, The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Eluxadoline.]
[N05AX16, brexpiprazole, The risk or severity of vasospastic reactions can be increased when Brexpiprazole is combined with Zolmitriptan.]
[G02CX02, flibanserin, The risk or severity of vasospastic reactions can be increased when Flibanserin is combined with Zolmitriptan.]
[N05AX15, cariprazine, The risk or severity of vasospastic reactions can be increased when Cariprazine is combined with Zolmitriptan.]
[M02AA25, aceclofenac, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Acemetacin.]
[S01EC01, acetazolamide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Acetazolamide.]
[N05AB07, acetophenazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Acetophenazine.]
[L01EB04, osimertinib, The serum concentration of Zolmitriptan can be decreased when it is combined with Osimertinib.]
[B01AC27, selexipag, Zolmitriptan may decrease the antihypertensive activities of Selexipag.]
[N05CA05, aprobarbital, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Aprobarbital.]
[M01AE16, alminoprofen, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Alminoprofen.]
[N03AX23, brivaracetam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Brivaracetam.]
[N05BA08, bromazepam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Bromazepam.]
[N04BC01, bromocriptine, Bromocriptine may increase the vasoconstricting activities of Zolmitriptan.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Alverine.]
[R06AB01, brompheniramine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dexbrompheniramine.]
[N06AA19, amineptin, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Amineptine.]
[C08CA01, amlodipine, Zolmitriptan may decrease the antihypertensive activities of Amlodipine.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Aniracetam.]
[A05AA04, obeticholic acid, The metabolism of Zolmitriptan can be decreased when combined with Obeticholic acid.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Zolmitriptan.]
[C07AA19, bupranolol, Zolmitriptan may decrease the antihypertensive activities of Bupranolol.]
[N07BC01, buprenorphine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Buspirone.]
[N02AF01, butorphanol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Butorphanol.]
[J01MA09, sparfloxacin, The metabolism of Zolmitriptan can be decreased when combined with Sparfloxacin.]
[S01GX07, azelastine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Zolmitriptan can be decreased when combined with Rucaparib.]
[A07EC04, balsalazide, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Balsalazide.]
[R03CC12, bambuterol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Bambuterol.]
[R03DA08, bamifylline, The metabolism of Bamifylline can be decreased when combined with Zolmitriptan.]
[N02BF02, pregabalin, The therapeutic efficacy of Zolmitriptan can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Beclamide.]
[N06BC01, caffeine, The metabolism of Zolmitriptan can be decreased when combined with Caffeine.]
[C09AA07, benazepril, Zolmitriptan may decrease the antihypertensive activities of Benazepril.]
[S01HA02, benoxinate, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Oxybuprocaine.]
[J01XX08, linezolid, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Zolmitriptan.]
[L04AB02, infliximab, The metabolism of Zolmitriptan can be increased when combined with Infliximab.]
[N04BD03, safinamide, The risk or severity of serotonin syndrome can be increased when Safinamide is combined with Zolmitriptan.]
[L01XX59, enasidenib, The metabolism of Zolmitriptan can be decreased when combined with Enasidenib.]
[C07AB07, bisoprolol, Zolmitriptan may decrease the antihypertensive activities of Bisoprolol.]
[R03AC17, bitolterol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Bitolterol.]
[J05AG03, efavirenz, The metabolism of Zolmitriptan can be decreased when combined with Efavirenz.]
[N04AA11, bornaprine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Bromperidol.]
[N05CD09, brotizolam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Brotizolam.]
[C04AX20, buflomedil, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Buflomedil.]
[M01AB07, bumadizone, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Bumadizone.]
[N05CA03, butobarbital, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Butobarbital.]
[N06AA15, butriptyline, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Butriptyline.]
[N01BX04, capsaicin, The metabolism of Zolmitriptan can be decreased when combined with Capsaicin.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Vinylbital.]
[C09AA01, captopril, Zolmitriptan may decrease the antihypertensive activities of Captopril.]
[N03AF01, carbamazepine, The metabolism of Zolmitriptan can be decreased when combined with Carbamazepine.]
[A03AA03, camylofine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Carbinoxamine.]
[L03AB06, interferon alfa-n1, The metabolism of Zolmitriptan can be decreased when combined with Interferon alfa-n1.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Zolmitriptan.]
[N03AX24, cannabidiol, The risk or severity of vasospastic reactions can be increased when Cannabidiol is combined with Zolmitriptan.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be decreased when combined with Zolmitriptan.]
[C07AB08, celiprolol, Zolmitriptan may decrease the antihypertensive activities of Celiprolol.]
[N03AX17, stiripentol, The metabolism of Zolmitriptan can be decreased when combined with Stiripentol.]
[S01GX12, cetirizine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Cetirizine.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Carbromal.]
[N01BA04, chloroprocaine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Chloroprocaine.]
[R06AA06, chlorphenoxamine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[M01AC05, lornoxicam, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Lornoxicam.]
[R03DA02, oxtriphylline, The metabolism of Oxtriphylline can be decreased when combined with Zolmitriptan.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Zolmitriptan.]
[R03BB08, revefenacin, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[L04AA39, emapalumab, The metabolism of Zolmitriptan can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The metabolism of Zolmitriptan can be decreased when combined with Carmustine.]
[L01EX13, gilteritinib, The therapeutic efficacy of Zolmitriptan can be decreased when used in combination with Gilteritinib.]
[C09AA08, cilazapril, Zolmitriptan may decrease the antihypertensive activities of Cilazapril.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Zolmitriptan.]
[A03FA08, cinitapride, The risk or severity of vasospastic reactions can be increased when Cinitapride is combined with Zolmitriptan.]
[P02BX04, triclabendazole, The metabolism of Zolmitriptan can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The risk or severity of hypertension can be increased when Esketamine is combined with Zolmitriptan.]
[L04AA42, siponimod, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Siponimod.]
[N06BA14, solriamfetol, The risk or severity of hypertension can be increased when Solriamfetol is combined with Zolmitriptan.]
[N06AX29, brexanolone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Brexanolone.]
[N05BA09, clobazam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Clobazam.]
[N05BA22, cloxazolam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Cloxazolam.]
[C09CA06, candesartan, Zolmitriptan may decrease the antihypertensive activities of Candesartan.]
[L04AB01, etanercept, The metabolism of Zolmitriptan can be increased when combined with Etanercept.]
[N05AA06, cyamemazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Cyamemazine.]
[C03BX03, cicletanine, Zolmitriptan may decrease the antihypertensive activities of Cicletanine.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zolmitriptan.]
[N07XX11, pitolisant, The metabolism of Zolmitriptan can be increased when combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Zolmitriptan.]
[C03AA09, cyclothiazide, Zolmitriptan may decrease the antihypertensive activities of Cyclothiazide.]
[G04BE04, yohimbine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Yohimbine.]
[A10AE03, insulin, regular, pork, The metabolism of Zolmitriptan can be increased when combined with Insulin pork.]
[N02CC08, lasmiditan, The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Zolmitriptan.]
[A16AX16, givosiran, The serum concentration of Zolmitriptan can be increased when it is combined with Givosiran.]
[R06AB06, dexbrompheniramine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dexbrompheniramine.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dezocine.]
[N05CM21, lemborexant, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Lemborexant.]
[N05AD10, lumateperone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Lumateperone.]
[M01AX21, diacetylrhein, The metabolism of Zolmitriptan can be decreased when combined with Diacerein.]
[S01AE06, gatifloxacin, The metabolism of Zolmitriptan can be decreased when combined with Gatifloxacin.]
[H02CA02, osilodrostat, The metabolism of Zolmitriptan can be decreased when combined with Osilodrostat.]
[N02CC07, frovatriptan, The risk or severity of vasospastic reactions can be increased when Frovatriptan is combined with Zolmitriptan.]
[G04CB02, dutasteride, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Dutasteride.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dichloralphenazone.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Zolmitriptan.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Difenoxin.]
[N02AA08, dihydrocodeine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dihydrocodeine.]
[N02CC06, eletriptan, The risk or severity of vasospastic reactions can be increased when Eletriptan is combined with Zolmitriptan.]
[M01AH02, rofecoxib, The metabolism of Zolmitriptan can be decreased when combined with Rofecoxib.]
[C01BD07, dronedarone, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Dronedarone.]
[N03AG02, dipropylacetamide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Valpromide.]
[N05BA02, chlordiazepoxide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Chlordiazepoxide.]
[C02AA06, methoserpidine, Zolmitriptan may decrease the antihypertensive activities of Methoserpidine.]
[A03AA08, dihexyverine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[L01EX17, capmatinib, The metabolism of Zolmitriptan can be decreased when combined with Capmatinib.]
[C01CA14, dopexamine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Dopexamine.]
[G04BD09, trospium, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[M01AC04, droxicam, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Droxicam.]
[L01EX22, selpercatinib, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Selpercatinib.]
[M02AA27, dexketoprofen, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Dexketoprofen.]
[N05CM02, chlormethiazole, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Clomethiazole.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Chlormezanone.]
[R02AD04, dyclonine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dyclonine.]
[C08CA17, levamlodipine, Zolmitriptan may decrease the antihypertensive activities of Levamlodipine.]
[N05CD14, remimazolam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Remimazolam.]
[N07XX04, sodium oxybate, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[L04AC19, satralizumab, The serum concentration of Zolmitriptan can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Zolmitriptan is combined with Oliceridine.]
[C03AA04, chlorothiazide, Zolmitriptan may decrease the antihypertensive activities of Chlorothiazide.]
[R06AB04, chlorpheniramine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Chlorpromazine.]
[N05AF03, chlorprothixene, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.]
[C03BA04, chlorthalidone, Zolmitriptan may decrease the antihypertensive activities of Chlorthalidone.]
[M03BB03, chlorzoxazone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Chlorzoxazone.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Etifoxine.]
[N02BA07, ethenzamide, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Ethenzamide.]
[N06BX18, vinpocetine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Vinpocetine.]
[N05BA18, ethyl loflazepate, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ethyl loflazepate.]
[M01AB08, etodolac, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Etofenamate.]
[L01FX21, naxitamab, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Naxitamab.]
[P03AX07, abametapir, The serum concentration of Zolmitriptan can be increased when it is combined with Abametapir.]
[V03AF12, trilaciclib, The metabolism of Zolmitriptan can be decreased when combined with Trilaciclib.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Febarbamate.]
[N03AX10, felbamate, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Felbamate.]
[M01AE05, fenbufen, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Fenbufen.]
[N06BA10, fenethylline, The metabolism of Fenethylline can be decreased when combined with Zolmitriptan.]
[C01CA19, fenoldopam, Zolmitriptan may decrease the antihypertensive activities of Fenoldopam.]
[N06BA08, fenozolone, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Fenozolone.]
[G04CB01, finasteride, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Finasteride.]
[J01MB07, flumequine, The metabolism of Zolmitriptan can be decreased when combined with Flumequine.]
[R03CC15, formoterol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Formoterol.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Trichloroethylene.]
[L03AB10, peginterferon alfa-2b, The metabolism of Zolmitriptan can be decreased when combined with Peginterferon alfa-2b.]
[H04AA02, dasiglucagon, Zolmitriptan may decrease the antihypertensive activities of Dasiglucagon.]
[A02BA01, cimetidine, The serum concentration of Zolmitriptan can be increased when it is combined with Cimetidine.]
[N02BF01, gabapentin, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Gabapentin.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Zolmitriptan.]
[J01MB06, cinoxacin, The metabolism of Zolmitriptan can be decreased when combined with Cinoxacin.]
[S03AA07, ciprofloxacin, The metabolism of Zolmitriptan can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, The risk or severity of serotonin syndrome can be increased when Citalopram is combined with Zolmitriptan.]
[H01AC07, somapacitan, The metabolism of Zolmitriptan can be increased when combined with Somapacitan.]
[P01CA03, fexinidazole, The metabolism of Zolmitriptan can be decreased when combined with Fexinidazole.]
[H01AC09, lonapegsomatropin, The metabolism of Zolmitriptan can be increased when combined with Lonapegsomatropin.]
[R06AA04, clemastine, The risk or severity of adverse effects can be increased when Clemastine is combined with Zolmitriptan.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be decreased when combined with Zolmitriptan.]
[R03CC13, clenbuterol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Clenbuterol.]
[N06AX25, St. John's wort extract, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Zolmitriptan.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The metabolism of Zolmitriptan can be decreased when combined with Pacritinib.]
[N06AA04, clomipramine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Clomipramine.]
[N03AE01, clonazepam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Clonazepam.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Zolmitriptan.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Clothiapine.]
[N05BA21, clotiazepam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Clotiazepam.]
[A04AA01, ondansetron, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ondansetron.]
[A04AA02, granisetron, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Granisetron.]
[N05AH02, clozapine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Clozapine.]
[N05BA13, halazepam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Halazepam.]
[H01AC08, somatrogon, The metabolism of Zolmitriptan can be increased when combined with Somatrogon.]
[S02DA02, cocaine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C02KB01, metyrosine, Zolmitriptan may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Zolmitriptan can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Proquazone.]
[R05DA04, codeine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Codeine.]
[M03AC05, hexafluorenium, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Hexafluronium.]
[A03AB10, hexocyclium, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[L04AA13, leflunomide, The serum concentration of Zolmitriptan can be decreased when it is combined with Leflunomide.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Desflurane.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tropisetron.]
[C04AX28, ifenprodil, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ifenprodil.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Imidazole salicylate.]
[B01AC10, indobufen, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Indobufen.]
[R06AX27, desloratadine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Desloratadine.]
[M01AH03, valdecoxib, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Valdecoxib.]
[A03AX10, isometheptene, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Isometheptene.]
[N02CC05, almotriptan, The risk or severity of vasospastic reactions can be increased when Almotriptan is combined with Zolmitriptan.]
[M01AH04, parecoxib, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Parecoxib.]
[S01AD03, acyclovir, The metabolism of Acyclovir can be decreased when combined with Zolmitriptan.]
[N05BA10, ketazolam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ketazolam.]
[M01AA06, kebuzone, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Kebuzone.]
[L01EA01, imatinib, The metabolism of Imatinib can be decreased when combined with Zolmitriptan.]
[C08CA09, lacidipine, Zolmitriptan may decrease the antihypertensive activities of Lacidipine.]
[N03AX09, lamotrigine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Lamotrigine.]
[N07BC04, lofexidine, The therapeutic efficacy of Zolmitriptan can be increased when used in combination with Lofexidine.]
[S01AE04, lomefloxacin, The metabolism of Zolmitriptan can be decreased when combined with Lomefloxacin.]
[M01AB09, lonazolac, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Lonazolac.]
[N05CD06, lormetazepam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Lormetazepam.]
[M02AA31, loxoprofen, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Loxoprofen.]
[C09AA03, lisinopril, Zolmitriptan may decrease the antihypertensive activities of Lisinopril.]
[C08CA11, manidipine, Zolmitriptan may decrease the antihypertensive activities of Manidipine.]
[A03AA04, mebeverine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Medifoxamine.]
[A08AA09, mefenorex, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Mefenorex.]
[N04AA03, methixene, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[R03CB02, methoxyphenamine, The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Methoxyphenamine.]
[R06AE03, cyclizine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Cyclizine.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Cyclobarbital.]
[C03DA04, eplerenone, Zolmitriptan may decrease the antihypertensive activities of Eplerenone.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Melperone.]
[C03AA07, cyclopenthiazide, Zolmitriptan may decrease the antihypertensive activities of Cyclopenthiazide.]
[N06AX07, minaprine, The risk or severity of serotonin syndrome can be increased when Minaprine is combined with Zolmitriptan.]
[S01XA18, cyclosporine, The risk or severity of hypertension can be increased when Cyclosporine is combined with Zolmitriptan.]
[N06AG02, moclobemide, The risk or severity of serotonin syndrome can be increased when Moclobemide is combined with Zolmitriptan.]
[N06BA07, modafinil, The metabolism of Zolmitriptan can be increased when combined with Armodafinil.]
[R06AX02, cyproheptadine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.]
[C09AA13, moexipril, Zolmitriptan may decrease the antihypertensive activities of Moexipril.]
[M02AA02, mofebutazone, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Morniflumate.]
[C02AC05, moxonidine, Zolmitriptan may decrease the antihypertensive activities of Moxonidine.]
[J05AF10, entecavir, The metabolism of Entecavir can be decreased when combined with Zolmitriptan.]
[M01AH05, etoricoxib, The metabolism of Etoricoxib can be decreased when combined with Zolmitriptan.]
[L01AX04, dacarbazine, The metabolism of Dacarbazine can be decreased when combined with Zolmitriptan.]
[M03CA01, dantrolene, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dantrolene.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Deanol.]
[C02CC04, debrisoquin, Zolmitriptan may decrease the antihypertensive activities of Debrisoquine.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.]
[M01AX01, nabumetone, The metabolism of Nabumetone can be decreased when combined with Zolmitriptan.]
[N05BA16, nordazepam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Nordazepam.]
[C07AB12, nebivolol, Zolmitriptan may decrease the antihypertensive activities of Nebivolol.]
[N06AX06, nefazodone, The risk or severity of serotonin syndrome can be increased when Nefazodone is combined with Zolmitriptan.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Niaprazine.]
[C01DX16, nicorandil, Zolmitriptan may decrease the antihypertensive activities of Nicorandil.]
[N03AG06, tiagabine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tiagabine.]
[C01CA23, theodrenaline, The metabolism of Theodrenaline can be decreased when combined with Zolmitriptan.]
[M03AC11, cisatracurium, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Cisatracurium.]
[C01CA05, norfenefrine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Norfenefrine.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Normethadone.]
[N06AB10, escitalopram, The risk or severity of serotonin syndrome can be increased when Escitalopram is combined with Zolmitriptan.]
[G04BD08, solifenacin, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.]
[A07EC03, olsalazine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Olsalazine.]
[N06AA01, desipramine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Desipramine.]
[H01BA02, desmopressin, The risk or severity of hypertension can be increased when Desmopressin is combined with Zolmitriptan.]
[C09XA02, aliskiren, Zolmitriptan may decrease the antihypertensive activities of Aliskiren.]
[M01AE12, oxaprozin, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Oxaprozin.]
[N03AF02, oxcarbazepine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Oxcarbazepine.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Oxiracetam.]
[N04AA08, dexetimide, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Zolmitriptan.]
[A03AA01, oxyphencyclimine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[L04AB04, adalimumab, The metabolism of Zolmitriptan can be increased when combined with Adalimumab.]
[N06BA02, dextroamphetamine, The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Zolmitriptan.]
[R05DA09, dextromethorphan, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dextromethorphan.]
[N03AC01, paramethadione, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Paramethadione.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dextromoramide.]
[N06AB05, paroxetine, The risk or severity of serotonin syndrome can be increased when Paroxetine is combined with Zolmitriptan.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be decreased when combined with Zolmitriptan.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Diamorphine.]
[C04AD01, pentifylline, The metabolism of Pentifylline can be decreased when combined with Zolmitriptan.]
[A03AX15, peppermint oil, The metabolism of Zolmitriptan can be decreased when combined with Peppermint oil.]
[N05BA01, diazepam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Diazepam.]
[N03AX07, phenacemide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Phenacemide.]
[V03AH01, diazoxide, Zolmitriptan may decrease the antihypertensive activities of Diazoxide.]
[N03AD02, phensuximide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Phensuximide.]
[N06AA08, dibenzepin, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Cinchocaine.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be decreased when combined with Zolmitriptan.]
[A03AA07, dicyclomine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[C02DG01, pinacidil, Zolmitriptan may decrease the antihypertensive activities of Pinacidil.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Pipamperone.]
[A03AB14, pipenzolate, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Zolmitriptan.]
[R03CC07, pirbuterol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Pirbuterol.]
[A08AA03, diethylpropion, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Diethylpropion.]
[C08CA03, isradipine, Zolmitriptan may decrease the antihypertensive activities of Isradipine.]
[A03AB11, poldine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[N02BA11, diflunisal, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Diflunisal.]
[C02DB01, dihydralazine, The metabolism of Zolmitriptan can be decreased when combined with Dihydralazine.]
[C04AE04, dihydroergocristine, Dihydroergocristine may increase the vasoconstricting activities of Zolmitriptan.]
[N02CA01, dihydroergotamine, The risk or severity of vasospastic reactions can be increased when Dihydroergotamine is combined with Zolmitriptan.]
[N02AA03, hydromorphone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Hydromorphone.]
[J05AE08, atazanavir, The metabolism of Zolmitriptan can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, Zolmitriptan may decrease the antihypertensive activities of Treprostinil.]
[D04AB07, pramoxine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Pramocaine.]
[C08DB01, diltiazem, Zolmitriptan may decrease the antihypertensive activities of Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dimenhydrinate.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Pridinol.]
[R06AB03, dimethindene, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[R03CC08, procaterol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Procaterol.]
[N03AG05, progabide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Progabide.]
[N06BC02, propentofylline, The metabolism of Propentofylline can be decreased when combined with Zolmitriptan.]
[N02BB04, propyphenazone, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Proglumetacin.]
[R03DA03, proxyphylline, The metabolism of Proxyphylline can be decreased when combined with Zolmitriptan.]
[R06AA02, diphenhydramine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Diphenhydramine.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Diphenoxylate.]
[N05CD10, quazepam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Quazepam.]
[C09AA06, quinapril, Zolmitriptan may decrease the antihypertensive activities of Quinapril.]
[N06BA11, dexmethylphenidate, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dexmethylphenidate.]
[N06AA23, quinupramine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Quinupramine.]
[A03FA02, cisapride, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Cisapride.]
[C09AA05, ramipril, Zolmitriptan may decrease the antihypertensive activities of Ramipril.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Remoxipride.]
[R03CC14, reproterol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Reproterol.]
[C01BA03, disopyramide, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.]
[S02AA12, rifamycin SV, The metabolism of Zolmitriptan can be decreased when combined with Rifamycin.]
[N07XX02, riluzole, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Riluzole.]
[N05AX08, risperidone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Risperidone.]
[R06AE09, levocetirizine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Levocetirizine.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Zolmitriptan.]
[J01MB01, rosoxacin, The metabolism of Zolmitriptan can be decreased when combined with Rosoxacin.]
[L01XG01, bortezomib, The metabolism of Zolmitriptan can be decreased when combined with Bortezomib.]
[G04BE08, tadalafil, Zolmitriptan may decrease the antihypertensive activities of Tadalafil.]
[S01BC05, ketorolac, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Ketorolac.]
[C02KX02, ambrisentan, Zolmitriptan may decrease the antihypertensive activities of Ambrisentan.]
[N02BA06, salsalate, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Salsalate.]
[R03AC12, salmeterol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Salmeterol.]
[C01CA07, dobutamine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Dobutamine.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Zolmitriptan.]
[C01CA04, dopamine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Dopamine.]
[N06AA16, dothiepin, The metabolism of Zolmitriptan can be decreased when combined with Dosulepin.]
[R07AB01, doxapram, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Doxapram.]
[N06AA12, doxepin, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Doxepin.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.]
[N06AB06, sertraline, The risk or severity of serotonin syndrome can be increased when Sertraline is combined with Zolmitriptan.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Sevoflurane.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.]
[A08AA10, sibutramine, The risk or severity of serotonin syndrome can be increased when Sibutramine is combined with Zolmitriptan.]
[C09AA11, spirapril, Zolmitriptan may decrease the antihypertensive activities of Spirapril.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Sultopride.]
[N02CC01, sumatriptan, The risk or severity of vasospastic reactions can be increased when Sumatriptan is combined with Zolmitriptan.]
[C07AB13, talinolol, Zolmitriptan may decrease the antihypertensive activities of Talinolol.]
[J01MA05, temafloxacin, The metabolism of Zolmitriptan can be decreased when combined with Temafloxacin.]
[M01AC02, tenoxicam, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Tenoxicam.]
[G04CA03, terazosin, Zolmitriptan may decrease the antihypertensive activities of Terazosin.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Zolmitriptan.]
[S01GA02, tetrahydrozoline, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Tetryzoline.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tetrazepam.]
[M03BX05, thiocolchicoside, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Thiocolchicoside.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Thiopropazate.]
[G04BD01, emepronium, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Emepronium.]
[N06AX14, tianeptine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tianeptine.]
[C09AA02, enalapril, Zolmitriptan may decrease the antihypertensive activities of Enalapril.]
[N05BA23, tofisopam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tofisopam.]
[M01AG02, tolfenamic acid, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Tolfenamic acid.]
[N06AG03, toloxatone, The risk or severity of serotonin syndrome can be increased when Toloxatone is combined with Zolmitriptan.]
[N06BA09, atomoxetine, The risk or severity of hypertension can be increased when Atomoxetine is combined with Zolmitriptan.]
[N03AX11, topiramate, The risk or severity of adverse effects can be increased when Topiramate is combined with Zolmitriptan.]
[C03CA04, torsemide, Zolmitriptan may decrease the antihypertensive activities of Torasemide.]
[R01AA09, tramazoline, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Tramazoline.]
[C09AA10, trandolapril, Zolmitriptan may decrease the antihypertensive activities of Trandolapril.]
[N05CD11, triazulenone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Loprazolam.]
[N05CC01, chloral hydrate, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Chloral hydrate.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Triclofos.]
[A03AB08, tridihexethyl, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Trimethobenzamide.]
[N04AA12, tropatepine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[R03CC11, tulobuterol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Tulobuterol.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Zolmitriptan.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Urapidil.]
[J01MA04, enoxacin, The metabolism of Zolmitriptan can be decreased when combined with Enoxacin.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Veralipride.]
[S01FB02, ephedrine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Ephedrine.]
[S01GX10, epinastine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Epinastine.]
[N06AX16, venlafaxine, The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Zolmitriptan.]
[C01CX07, xamoterol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Xamoterol.]
[S01GA03, xylometazoline, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Xylometazoline.]
[S01EA01, epinephrine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Epinephrine.]
[C09AA15, zofenopril, Zolmitriptan may decrease the antihypertensive activities of Zofenopril.]
[N05CF02, zolpidem, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[M01AB04, zomepirac, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Zomepirac.]
[N03AX15, zonisamide, The metabolism of Zolmitriptan can be decreased when combined with Zonisamide.]
[N05CF01, zopiclone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Zopiclone.]
[N05AX11, zotepine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Zotepine.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Guanfacine.]
[C01BG01, moricizine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Moricizine.]
[G02AB03, ergonovine, Ergometrine may increase the vasoconstricting activities of Zolmitriptan.]
[C04AE01, ergoloid mesylates, USP, Ergoloid mesylate may increase the vasoconstricting activities of Zolmitriptan.]
[N02CA02, ergotamine, The risk or severity of vasospastic reactions can be increased when Ergotamine is combined with Zolmitriptan.]
[N05CD04, estazolam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Estazolam.]
[H05BX01, cinacalcet, The metabolism of Cinacalcet can be decreased when combined with Zolmitriptan.]
[G03CA03, estradiol, The metabolism of Zolmitriptan can be decreased when combined with Estradiol.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Zolmitriptan can be decreased when combined with Conjugated estrogens.]
[J04AK02, ethambutol, The metabolism of Zolmitriptan can be decreased when combined with Ethambutol.]
[C01CA15, gepefrine, The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Gepefrine.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Zolmitriptan.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Zolmitriptan.]
[N04AA05, profenamine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Profenamine.]
[N03AD01, ethosuximide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ethosuximide.]
[N03AB01, ethotoin, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ethotoin.]
[M01AC06, meloxicam, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Meloxicam.]
[S01XA06, ethylmorphine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ethylmorphine.]
[C01CA01, etilefrine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Etilefrine.]
[N01AX07, etomidate, The risk or severity of adverse effects can be increased when Etomidate is combined with Zolmitriptan.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Zolmitriptan.]
[N05AE03, sertindole, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Sertindole.]
[R06AX12, terfenadine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Terfenadine.]
[N06AX12, bupropion, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Bupropion.]
[N06AB08, fluvoxamine, The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Zolmitriptan.]
[C01BB03, tocainide, The metabolism of Zolmitriptan can be decreased when combined with Tocainide.]
[A02BA03, famotidine, The metabolism of Zolmitriptan can be decreased when combined with Famotidine.]
[P02CA03, albendazole, The metabolism of Zolmitriptan can be increased when combined with Albendazole.]
[C08CA02, felodipine, Zolmitriptan may decrease the antihypertensive activities of Felodipine.]
[N03AX26, fenfluramine, The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Fenfluramine.]
[M01AE04, fenoprofen, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Fenoprofen.]
[R03CC04, fenoterol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Fenoterol.]
[N02AB03, fentanyl, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fentanyl.]
[R03CC02, albuterol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Salbutamol.]
[G04BD02, flavoxate, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Zolmitriptan.]
[N02BG04, floctafenine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Floctafenine.]
[N07CA03, flunarizine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Flunarizine.]
[N05CD03, flunitrazepam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Flunitrazepam.]
[N06AA14, melitracen, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Melitracen.]
[V03AZ01, ethanol, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Zolmitriptan.]
[N06AB03, fluoxetine, The risk or severity of serotonin syndrome can be increased when Fluoxetine is combined with Zolmitriptan.]
[N05AF01, flupenthixol, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.]
[N05AB02, fluphenazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluphenazine.]
[N05CD01, flurazepam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Flurazepam.]
[S01BC04, flurbiprofen, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Flurbiprofen.]
[N05AG01, fluspirilene, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluspirilene.]
[L02BB01, flutamide, The metabolism of Flutamide can be decreased when combined with Zolmitriptan.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Zolmitriptan.]
[N06BX17, adrafinil, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Adrafinil.]
[M03AA01, alcuronium, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Alcuronium.]
[G01AX06, furazolidone, The risk or severity of serotonin syndrome can be increased when Furazolidone is combined with Zolmitriptan.]
[C03CA01, furosemide, Zolmitriptan may decrease the antihypertensive activities of Furosemide.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Amisulpride.]
[M03AC02, gallamine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Gallamine.]
[N03AA04, barbexaclone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Barbexaclone.]
[N06AX08, bifemelane, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Bifemelane.]
[C10AB04, gemfibrozil, The metabolism of Zolmitriptan can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Zolmitriptan.]
[N04BC06, cabergoline, The risk or severity of vasospastic reactions can be increased when Cabergoline is combined with Zolmitriptan.]
[C01CA21, cafedrine, The metabolism of Cafedrine can be decreased when combined with Zolmitriptan.]
[N03AD03, methsuximide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Methsuximide.]
[N01AH02, alfentanil, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Alfentanil.]
[N05CM18, dexmedetomidine, The metabolism of Zolmitriptan can be decreased when combined with Dexmedetomidine.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Glutethimide.]
[C05AE01, nitroglycerin, Zolmitriptan may decrease the antihypertensive activities of Nitroglycerin.]
[C02CA04, doxazosin, Zolmitriptan may decrease the antihypertensive activities of Doxazosin.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Zolmitriptan.]
[C07AB09, esmolol, Zolmitriptan may decrease the antihypertensive activities of Esmolol.]
[B01AA12, fluindione, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluindione.]
[C09AA09, fosinopril, Zolmitriptan may decrease the antihypertensive activities of Fosinopril.]
[S01EX01, guanethidine, Zolmitriptan may decrease the antihypertensive activities of Guanethidine.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Zolmitriptan.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Halothane.]
[N05AH04, quetiapine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Iprazochrome.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Allobarbital.]
[C09CA01, losartan, Zolmitriptan may decrease the antihypertensive activities of Losartan.]
[A07EC02, mesalamine, The risk or severity of hypertension can be increased when Mesalazine is combined with Zolmitriptan.]
[N05CA16, hexobarbital, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Hexobarbital.]
[R03CC05, hexoprenaline, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Hexoprenaline.]
[J05AG01, nevirapine, The metabolism of Zolmitriptan can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, Zolmitriptan may decrease the antihypertensive activities of Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Nimesulide.]
[C09AA04, perindopril, Zolmitriptan may decrease the antihypertensive activities of Perindopril.]
[C02DB02, hydralazine, Zolmitriptan may decrease the antihypertensive activities of Hydralazine.]
[C03AA03, hydrochlorothiazide, Zolmitriptan may decrease the antihypertensive activities of Hydrochlorothiazide.]
[R05DA03, hydrocodone, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[C03AA02, hydroflumethiazide, Zolmitriptan may decrease the antihypertensive activities of Hydroflumethiazide.]
[G04BD06, propiverine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Propiverine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Prothipendyl.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.]
[C02AC06, rilmenidine, Zolmitriptan may decrease the antihypertensive activities of Rilmenidine.]
[R02AX02, ibuprofen, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Ibuprofen.]
[H01AC02, somatrem, The metabolism of Zolmitriptan can be increased when combined with Somatrem.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Sufentanil.]
[N06AA02, imipramine, The metabolism of Zolmitriptan can be decreased when combined with Imipramine.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tizanidine.]
[C03BA11, indapamide, Zolmitriptan may decrease the antihypertensive activities of Indapamide.]
[S01BC01, indomethacin, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Indomethacin.]
[C02CA02, indoramin, Zolmitriptan may decrease the antihypertensive activities of Indoramin.]
[L03AB04, interferon alfa-2a, The metabolism of Zolmitriptan can be decreased when combined with Interferon alfa-2a.]
[L03AB05, interferon alfa-2b, The metabolism of Zolmitriptan can be decreased when combined with Interferon alfa-2b.]
[N06AX17, milnacipran, The risk or severity of serotonin syndrome can be increased when Milnacipran is combined with Zolmitriptan.]
[A03AA30, piperidolate, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[N01BB08, articaine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Articaine.]
[N05BA12, alprazolam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Alprazolam.]
[N05CH02, ramelteon, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ramelteon.]
[R06AE01, buclizine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[L01XX35, anagrelide, The metabolism of Zolmitriptan can be decreased when combined with Anagrelide.]
[C07AA01, alprenolol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Alprenolol.]
[L03AB09, interferon alfacon-1, The metabolism of Zolmitriptan can be decreased when combined with Interferon alfacon-1.]
[N06AA13, iprindole, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Iprindole.]
[N06AF05, iproniazid, The risk or severity of serotonin syndrome can be increased when Iproniazid is combined with Zolmitriptan.]
[J05AB13, penciclovir, The metabolism of Zolmitriptan can be decreased when combined with Penciclovir.]
[N05AA07, chlorproethazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Chlorproethazine.]
[N06AF01, isocarboxazid, The risk or severity of serotonin syndrome can be increased when Isocarboxazid is combined with Zolmitriptan.]
[R03CC06, isoetharine, The risk or severity of hypertension can be increased when Isoetharine is combined with Zolmitriptan.]
[C09AA16, imidapril, Zolmitriptan may decrease the antihypertensive activities of Imidapril.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Isoflurane.]
[N04BX02, entacapone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Entacapone.]
[J04AC01, isoniazid, The metabolism of Zolmitriptan can be decreased when combined with Isoniazid.]
[R03CB01, isoproterenol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Isoprenaline.]
[C04AA01, isoxsuprine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Isoxsuprine.]
[N06AX18, reboxetine, The risk or severity of adverse effects can be increased when Reboxetine is combined with Zolmitriptan.]
[H01AC01, somatropin, The metabolism of Zolmitriptan can be increased when combined with Somatotropin.]
[L04AC07, tocilizumab, The metabolism of Zolmitriptan can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ketamine.]
[C02KD01, ketanserin, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ketanserin.]
[J02AB02, ketoconazole, The metabolism of Zolmitriptan can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.]
[M02AA10, ketoprofen, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Ketoprofen.]
[V03AC03, deferasirox, The metabolism of Zolmitriptan can be decreased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Zolmitriptan can be increased when combined with Abatacept.]
[C01CA22, arbutamine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Arbutamine.]
[N04BC09, rotigotine, The risk or severity of vasospastic reactions can be increased when Rotigotine is combined with Zolmitriptan.]
[J01MB02, nalidixic acid, The metabolism of Zolmitriptan can be decreased when combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Tiaprofenic acid.]
[C07AG01, labetalol, Zolmitriptan may decrease the antihypertensive activities of Labetalol.]
[N04BB01, amantadine, The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Amantadine.]
[C02AA05, deserpidine, Zolmitriptan may decrease the antihypertensive activities of Deserpidine.]
[N03AX18, lacosamide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Lacosamide.]
[N04BA01, levodopa, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Levodopa.]
[S02DA01, lidocaine, The metabolism of Zolmitriptan can be decreased when combined with Lidocaine.]
[N06BA13, armodafinil, The metabolism of Zolmitriptan can be increased when combined with Armodafinil.]
[N02CA07, lisuride, The risk or severity of vasospastic reactions can be increased when Lisuride is combined with Zolmitriptan.]
[N06AA07, lofepramine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Lofepramine.]
[N05BA06, lorazepam, The risk or severity of adverse effects can be increased when Lorazepam is combined with Zolmitriptan.]
[N05AH01, loxapine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Loxapine.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Zolmitriptan can be increased when used in combination with Magnesium sulfate.]
[N06AA21, maprotiline, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.]
[A08AA05, mazindol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Mazindol.]
[C02BB01, mecamylamine, Zolmitriptan may decrease the antihypertensive activities of Mecamylamine.]
[R06AE05, meclizine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Meclizine.]
[M02AA18, meclofenamic acid, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Meclofenamic acid.]
[N05BA03, medazepam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Medazepam.]
[N05CH01, melatonin, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Melatonin.]
[N02AB02, meperidine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Meperidine.]
[C01CA11, mephentermine, The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Mephentermine.]
[N03AB04, mephenytoin, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Mephenytoin.]
[N03AA01, mephobarbital, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Methylphenobarbital.]
[N01BB03, mepivacaine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Mepivacaine.]
[N05BC01, meprobamate, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Meprobamate.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Meptazinol.]
[N05AC03, mesoridazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Mesoridazine.]
[N05AX13, paliperidone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Paliperidone.]
[C01CA09, metaraminol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Metaraminol.]
[A04AA04, dolasetron, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dolasetron.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Zolmitriptan.]
[N06BA03, methamphetamine, The metabolism of Zolmitriptan can be decreased when combined with Metamfetamine.]
[A03AB07, methantheline, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Methapyrilene.]
[N05CM01, methaqualone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Methaqualone.]
[N03AA30, metharbital, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Metharbital.]
[G02CB05, metergoline, Metergoline may increase the vasoconstricting activities of Zolmitriptan.]
[H03BB02, methimazole, The metabolism of Zolmitriptan can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, The metabolism of Pemetrexed can be decreased when combined with Zolmitriptan.]
[M03BA03, methocarbamol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Methocarbamol.]
[N05CA15, methohexital, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Methohexital.]
[N02BG08, ziconotide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ziconotide.]
[N05AA02, methotrimeprazine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.]
[C01CA10, methoxamine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Methoxamine.]
[D05BA02, methoxsalen, The metabolism of Zolmitriptan can be decreased when combined with Methoxsalen.]
[N02BG09, methoxyflurane, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Methoxyflurane.]
[C02AB01, methyldopa, Zolmitriptan may decrease the antihypertensive activities of Methyldopa.]
[V04CG05, methylene blue, Zolmitriptan may increase the serotonergic activities of Methylene blue.]
[G02AB01, methylergonovine, Methylergometrine may increase the vasoconstricting activities of Zolmitriptan.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Zolmitriptan.]
[N06BA04, methylphenidate, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Methylphenidate.]
[N03AF03, rufinamide, The risk or severity of adverse effects can be increased when Rufinamide is combined with Zolmitriptan.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Methyprylon.]
[N02CA04, methysergide, Methysergide may increase the vasoconstricting activities of Zolmitriptan.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Zolmitriptan.]
[C03BA08, metolazone, Zolmitriptan may decrease the antihypertensive activities of Metolazone.]
[C07AB02, metoprolol, Zolmitriptan may decrease the antihypertensive activities of Metoprolol.]
[C01BB02, mexiletine, The metabolism of Zolmitriptan can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Mianserin.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Zolmitriptan.]
[N05CD08, midazolam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Midazolam.]
[C01CA17, midodrine, The risk or severity of hypertension can be increased when Midodrine is combined with Zolmitriptan.]
[C09CA03, valsartan, Zolmitriptan may decrease the antihypertensive activities of Valsartan.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.]
[D11AX01, minoxidil, Zolmitriptan may decrease the antihypertensive activities of Minoxidil.]
[N06BA12, lisdexamfetamine, The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Lisdexamfetamine.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Molindone.]
[C01BD01, amiodarone, The metabolism of Zolmitriptan can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Zolmitriptan.]
[A04AA05, palonosetron, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Palonosetron.]
[L04AB05, certolizumab pegol, The metabolism of Zolmitriptan can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be decreased when combined with Zolmitriptan.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Zolmitriptan.]
[M03AC03, vecuronium, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Vecuronium.]
[N05CA02, amobarbital, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Amobarbital.]
[R03BB01, ipratropium bromide, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
[N06AA17, amoxapine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.]
[N03AB05, fosphenytoin, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fosphenytoin.]
[L03AB08, interferon beta-1b, The metabolism of Zolmitriptan can be decreased when combined with Interferon beta-1b.]
[C07AA12, nadolol, Zolmitriptan may decrease the antihypertensive activities of Nadolol.]
[N04BC04, ropinirole, Zolmitriptan may increase the sedative activities of Ropinirole.]
[J01CF06, nafcillin, The metabolism of Zolmitriptan can be increased when combined with Nafcillin.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Nalbuphine.]
[N07BB04, naltrexone, The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Naltrexone.]
[L04AC03, anakinra, The metabolism of Zolmitriptan can be increased when combined with Anakinra.]
[S01GA01, naphazoline, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Naphazoline.]
[N06BA01, amphetamine, The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Zolmitriptan.]
[M02AA12, naproxen, The metabolism of Naproxen can be decreased when combined with Zolmitriptan.]
[N06AX21, duloxetine, The risk or severity of serotonin syndrome can be increased when Duloxetine is combined with Zolmitriptan.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tolcapone.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Remifentanil.]
[N05AX14, iloperidone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Iloperidone.]
[N06AX23, desvenlafaxine, The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Zolmitriptan.]
[C09CA07, telmisartan, Zolmitriptan may decrease the antihypertensive activities of Telmisartan.]
[N06AF02, nialamide, The risk or severity of serotonin syndrome can be increased when Nialamide is combined with Zolmitriptan.]
[C08CA04, nicardipine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Nicardipine.]
[C04AE02, nicergoline, Nicergoline may increase the vasoconstricting activities of Zolmitriptan.]
[P02DA01, niclosamide, The metabolism of Zolmitriptan can be decreased when combined with Niclosamide.]
[N07BA01, nicotine, The metabolism of Zolmitriptan can be decreased when combined with Nicotine.]
[C08CA05, nifedipine, The metabolism of Zolmitriptan can be decreased when combined with Nifedipine.]
[M02AA17, niflumic acid, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Niflumic acid.]
[C08CA06, nimodipine, Zolmitriptan may decrease the antihypertensive activities of Nimodipine.]
[C08CA07, nisoldipine, Zolmitriptan may decrease the antihypertensive activities of Nisoldipine.]
[N05CD02, nitrazepam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Nitrazepam.]
[C08CA08, nitrendipine, Zolmitriptan may decrease the antihypertensive activities of Nitrendipine.]
[R07AX01, nitric oxide, The metabolism of Zolmitriptan can be decreased when combined with Nitric Oxide.]
[N05CF03, zaleplon, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Zaleplon.]
[N04BC05, pramipexole, Zolmitriptan may increase the sedative activities of Pramipexole.]
[C02DD01, nitroprusside, Zolmitriptan may decrease the antihypertensive activities of Nitroprusside.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Nitrous oxide.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Nomifensine.]
[C01CA03, norepinephrine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Norepinephrine.]
[S01AE02, norfloxacin, The metabolism of Zolmitriptan can be decreased when combined with Norfloxacin.]
[C02KX01, bosentan, Zolmitriptan may decrease the antihypertensive activities of Bosentan.]
[N06AA10, nortriptyline, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.]
[L03AB07, interferon beta-1a, The metabolism of Zolmitriptan can be decreased when combined with Interferon beta-1a.]
[G02CA02, nylidrin, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Nylidrin.]
[S02AA16, ofloxacin, The metabolism of Zolmitriptan can be decreased when combined with Ofloxacin.]
[L04AC04, rilonacept, The metabolism of Zolmitriptan can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Zolmitriptan can be increased when combined with Omeprazole.]
[N06AA05, opipramol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Opipramol.]
[N02AA02, opium, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Opium.]
[R03CB03, metaproterenol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Orciprenaline.]
[N05BA04, oxazepam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Oxazepam.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Oxprenolol.]
[N02AA05, oxycodone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Oxycodone.]
[C01DX03, oxyfedrine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Oxyfedrine.]
[S01GA04, oxymetazoline, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Oxymetazoline.]
[N02AA11, oxymorphone, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Oxymorphone.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Oxypertine.]
[S01BC02, oxyphenbutazone, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Oxyphenbutazone.]
[A03AB03, oxyphenonium, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[N05AH05, asenapine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Asenapine.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.]
[M03AC01, pancuronium, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Pancuronium.]
[N05CC05, paraldehyde, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[C02KC01, pargyline, The risk or severity of serotonin syndrome can be increased when Pargyline is combined with Zolmitriptan.]
[J01MA03, pefloxacin, The metabolism of Zolmitriptan can be decreased when combined with Pefloxacin.]
[G04BD11, fesoterodine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Penbutolol.]
[N05AG03, penfluridol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Penfluridol.]
[N02AD01, pentazocine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Pentazocine.]
[N05CA01, pentobarbital, The risk or severity of adverse effects can be increased when Pentobarbital is combined with Zolmitriptan.]
[C04AD03, pentoxifylline, The metabolism of Pentoxifylline can be decreased when combined with Zolmitriptan.]
[N05AB10, perazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Perazine.]
[N04BC02, pergolide, Pergolide may increase the vasoconstricting activities of Zolmitriptan.]
[N05AB03, perphenazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Perphenazine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Zolmitriptan.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Phenazocine.]
[N06AF03, phenelzine, The risk or severity of serotonin syndrome can be increased when Phenelzine is combined with Zolmitriptan.]
[B01AA02, phenindione, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Phenindione.]
[N03AA02, phenobarbital, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Phenobarbital.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Phenoperidine.]
[C04AX02, phenoxybenzamine, Zolmitriptan may decrease the antihypertensive activities of Phenoxybenzamine.]
[B01AA04, phenprocoumon, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Phenprocoumon.]
[A08AA01, phentermine, The metabolism of Zolmitriptan can be decreased when combined with Phentermine.]
[V03AB36, phentolamine, Zolmitriptan may decrease the antihypertensive activities of Phentolamine.]
[M02AA01, phenylbutazone, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Phenylbutazone.]
[S01GA05, phenylephrine, The metabolism of Zolmitriptan can be increased when combined with Phenylephrine.]
[R01BA01, phenylpropanolamine, The metabolism of Zolmitriptan can be decreased when combined with Phenylpropanolamine.]
[N03AB02, phenytoin, The risk or severity of adverse effects can be increased when Phenytoin is combined with Zolmitriptan.]
[L04AB06, golimumab, The metabolism of Zolmitriptan can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The metabolism of Zolmitriptan can be decreased when combined with Levofloxacin.]
[C08CX01, mibefradil, The metabolism of Zolmitriptan can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Pimozide.]
[C07AA03, pindolol, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Pindolol.]
[N05AC04, pipothiazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Pipotiazine.]
[C09CA02, eprosartan, Zolmitriptan may decrease the antihypertensive activities of Eprosartan.]
[A02BX03, pirenzepine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Piritramide.]
[S01BC06, piroxicam, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Piroxicam.]
[J01MA11, grepafloxacin, The metabolism of Zolmitriptan can be decreased when combined with Grepafloxacin.]
[N02CX01, pizotyline, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.]
[C09CA04, irbesartan, Zolmitriptan may decrease the antihypertensive activities of Irbesartan.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Proxibarbal.]
[A10BG02, rosiglitazone, The metabolism of Zolmitriptan can be decreased when combined with Rosiglitazone.]
[A03AE01, alosetron, The metabolism of Zolmitriptan can be decreased when combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Zolmitriptan can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Zolmitriptan may decrease the antihypertensive activities of Polythiazide.]
[J05AE03, ritonavir, The metabolism of Zolmitriptan can be increased when combined with Ritonavir.]
[C07AB01, practolol, Zolmitriptan may decrease the antihypertensive activities of Practolol.]
[N05BA11, prazepam, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Prazepam.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Zolmitriptan.]
[C02CA01, prazosin, Zolmitriptan may decrease the antihypertensive activities of Prazosin.]
[N01BB04, prilocaine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Zolmitriptan can be increased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Zolmitriptan can be increased when combined with Primidone.]
[S01HA05, procaine, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Zolmitriptan.]
[L01XB01, procarbazine, The risk or severity of serotonin syndrome can be increased when Procarbazine is combined with Zolmitriptan.]
[N05AB04, prochlorperazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Prochlorperazine.]
[N04AA04, procyclidine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[N05AA03, promazine, The metabolism of Zolmitriptan can be decreased when combined with Promazine.]
[R06AD02, promethazine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Promethazine.]
[C01BC03, propafenone, The metabolism of Zolmitriptan can be decreased when combined with Propafenone.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Propanidid.]
[A03AB05, propantheline, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Periciazine.]
[N05CM06, propiomazine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.]
[N01AX10, propofol, The metabolism of Zolmitriptan can be decreased when combined with Propofol.]
[N02AC04, propoxyphene, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dextropropoxyphene.]
[C07AA05, propranolol, The serum concentration of the active metabolites of Zolmitriptan can be reduced when Zolmitriptan is used in combination with Propranolol resulting in a loss in efficacy.]
[N02CC04, rizatriptan, The risk or severity of vasospastic reactions can be increased when Rizatriptan is combined with Zolmitriptan.]
[B01AC09, epoprostenol, Zolmitriptan may decrease the antihypertensive activities of Epoprostenol.]
[N06AA11, protriptyline, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Protriptyline.]
[R01BA02, pseudoephedrine, The metabolism of Zolmitriptan can be decreased when combined with Pseudoephedrine.]
[N05AX12, aripiprazole, The risk or severity of vasospastic reactions can be increased when Aripiprazole is combined with Zolmitriptan.]
[A03AB15, diphemanil, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, The risk or severity of adverse effects can be increased when Talbutal is combined with Zolmitriptan.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Captodiame.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Styramate.]
[P02CC01, pyrantel, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Pyrantel.]
[R06AC01, pyrilamine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Mepyramine.]
[C01BA01, quinidine, The metabolism of Zolmitriptan can be decreased when combined with Quinidine.]
[P01BC01, quinine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Zolmitriptan can be decreased when combined with Ranitidine.]
[C02AA01, rescinnamine, Zolmitriptan may decrease the antihypertensive activities of Rescinnamine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Reserpine.]
[J04AB02, rifampin, The metabolism of Zolmitriptan can be increased when combined with Rifampicin.]
[R03AC05, rimiterol, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Rimiterol.]
[G02CA01, ritodrine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Ritodrine.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Oxitriptan.]
[N02BA05, salicylamide, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of hypertension can be increased when Zolmitriptan is combined with Salicylic acid.]
[S01FA02, scopolamine, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Scopolamine.]
[N05CA06, secobarbital, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Secobarbital.]
[N04BD01, selegiline, The risk or severity of serotonin syndrome can be increased when Selegiline is combined with Zolmitriptan.]
[N03AG01, valproic acid, The metabolism of Zolmitriptan can be decreased when combined with Valproic acid.]
[N06AF04, tranylcypromine, Triptans - monoamine oxidase (MAO) inhibitors]
[N06AF01, isocarboxazid, Triptans - monoamine oxidase (MAO) inhibitors]
[V04CG05, methylene blue, Triptans - monoamine oxidase (MAO) inhibitors]
[N06AF03, phenelzine, Triptans - monoamine oxidase (MAO) inhibitors]
